Bluejay Diagnostics, Inc. (BJDX) Operating income 2020–2025
Bluejay Diagnostics, Inc. (BJDX) annual operating income history from SEC filings — each fiscal year as reported.
-$7.0MFY2025 · since FY2020: -$1.2M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +3.0% |
| FY2024 | -$7.2M | +30.5% |
| FY2023 | -$10.3M | -10.7% |
| FY2022 | -$9.3M | -188.5% |
| FY2021 | -$3.2M | -170.0% |
| FY2020 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BJDX financial trends
BJDX RevenueBJDX Net incomeBJDX Net marginBJDX Gross profitBJDX Gross marginBJDX Operating marginBJDX Operating cash flowBJDX Free cash flowBJDX Capital expendituresBJDX Return on equityBJDX Stock buybacksBJDX Dividends paidBJDX Total assetsBJDX Total liabilitiesBJDX Shareholders’ equityBJDX overview →